Close Menu
Home » biomarker detection

biomarker detection

Jul 11, 2019

Microsoft, Seattle Children's Seek Genetic Markers for SIDS Through Whole-Genome Sequencing

Premium

The longtime quest of one Microsoft data scientist to stop infant crib deaths has grown into a genomics and AI research program with lofty goals.

Jun 13, 2019

Bio-Techne Gets New York State Approval for Prostate Cancer Test

The firm said that with the approval, the firm's liquid biopsy-based ExoDx Prostate IntelliScore (EPI) test is now available in every state.

Apr 22, 2019

Researchers Seek Best Approach to Identify Lung Cancer Patients With MET-Based Resistance

Premium

The TATTON study found a combination therapy could treat some EGFR-positive lung cancer patients who developed MET-based resistance, but the best way to gauge MET status isn't yet clear.

Feb 19, 2019

NGS Panel Developed to Help Researchers ID Actionable Breast Cancer Mutations, Rx Targets

Premium

The MammaSeq assay comprises 79 genes and 1,369 mutations in breast cancer that could be used as potential downstream therapeutic targets. 

Oct 22, 2018

OncoDNA Signs Distribution Agreements in Turkey, Romania

OncoDNA anticipates a strong increase in the use of OncoDNA profiling products in Europe with the partnerships with Gammaray and AMS.

Sep 27, 2018

Immunovia Delays Launch of Pancreatic Cancer Assay Citing Sample Prep Issues

Premium

The company also published a study describing ImmRay PanCan-D biomarker signature that it said could be used to detect early-stage pancreatic cancer.

Sep 26, 2018

Konica Minolta Launches Precision Medicine Business

KMPJM will provide diagnostic and prognostic testing services based on genes, proteins, and other molecules to aid physicians in assessing and treating patients.

Aug 10, 2018

UCSD Researchers Establish Mutational Landscape of Appendiceal Cancer

The researchers distinguished histologic subtypes of appendiceal cancer and confirmed that it is distinct from colorectal and other GI cancers.

May 29, 2018

PavMed Spinoff Lucid Diagnostics Aims to Market Molecular Barrett's Esophagus Test in 2019

Premium

PavMed subsidiary Lucid will commercialize Case Western's EsoCheck technology to detect Barrett's esophagus, a precursor to esophageal cancer.

May 14, 2018

Lucid Diagnostics Licenses Barrett's Esophagus Biomarker Tech from CWRU

PavMed subsidiary Lucid Diagnostics secured exclusive global rights to develop and commercialize genetic biomarker-based diagnostic tests using EsoCheck technology.

Pages

The Scan

Suspect Confesses in Killing of Developmental Biologist

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

Concerning Links

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

For Coverage

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

PNAS Studies Tackle Syndromic Craniosynostosis, Colorectal Cancer Drivers, More

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.

What's Popular?

In biomarker detection

  1. Microsoft, Seattle Children's Seek Genetic Markers for SIDS Through Whole-Genome Sequencing

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.